Ansa Biotechnologies

Biotechnology · Emeryville, CA · Founded 2018 · Privately Held (backing)

Developer of a novel DNA synthesis technology designed to simplify the biological research process. Ansa Biotechnologies is based in Emeryville, CA and was founded in 2018. It was valued at $269 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $140 million across 4 recorded rounds; the latest was a $46.4 million early-stage round in Jun 2024.

PMV mark · valuation
$269.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$139.6M
Last round
Early Stage VC
Jun 2024

Who backs Ansa Biotechnologies?

27 investors
InvestorType
Y CombinatorOther
US National Science FoundationOther
Mubadala Investment CompanyOther
Metaplanet HoldingsVenture capital
RA Capital ManagementAsset manager
University of CaliforniaOther
SoftBank Group—
Fifty YearsVenture capital
Horizons VenturesVenture capital
Magnetar CapitalHedge fund
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ansa Biotechnologies investors

27 investors are on record for Ansa Biotechnologies, including Y Combinator, US National Science Foundation, Mubadala Investment Company and Metaplanet Holdings. By type, the record holds 7 venture capital firms and 1 family office. The early-stage round in Jun 2024 drew 41 investors.

Free account
More of Ansa Biotechnologies with a free account
  • ·The complete investor list: 27 names
  • ·Watch Ansa Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Ansa Biotechnologies in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View